Cargando…

Persistence of envelopes in different CD4(+) T-cell subsets in antiretroviral therapy-suppressed people with HIV

Despite suppressive antiretroviral therapy (ART), HIV can persist in a diverse range of CD4(+) T-cell subsets. Through longitudinal env sampling from people with HIV (PWH) on ART, we characterized the persistence and phenotypic properties of HIV envs over two time-points (T1 and T2). METHODS: Longit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gartner, Matthew J., Tumpach, Carolin, Dantanarayana, Ashanti, Stern, Jared, Zerbato, Jennifer M., Chang, J. Judy, Angelovich, Thomas A., Anderson, Jenny L., Symons, Jori, Deeks, Steve G., Flynn, Jacqueline K., Lewin, Sharon R., Churchill, Melissa J., Gorry, Paul R., Roche, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794144/ https://www.ncbi.nlm.nih.gov/pubmed/36541637 http://dx.doi.org/10.1097/QAD.0000000000003424

Ejemplares similares

Longitudinal analysis of subtype C envelope tropism for memory CD4(+) T cell subsets over the first 3 years of untreated HIV-1 infection
por: Gartner, Matthew J., et al.
Publicado: (2020)

HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy
por: Zerbato, Jennifer M., et al.
Publicado: (2022)

Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
por: Tumpach, Carolin, et al.
Publicado: (2023)

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
por: Zerbato, Jennifer M., et al.
Publicado: (2021)

Understanding the mechanisms driving the spread of subtype C HIV-1
por: Gartner, Matthew J., et al.
Publicado: (2020)

Memory CD4(+) T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency
por: Rasmussen, Thomas A., et al.
Publicado: (2022)

Human Immunodeficiency Virus (HIV)–Infected CCR6(+) Rectal CD4(+) T Cells and HIV Persistence On Antiretroviral Therapy
por: Anderson, Jenny L, et al.
Publicado: (2020)

Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc
por: Borm, Katharina, et al.
Publicado: (2016)

Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cells
por: Cashin, Kieran, et al.
Publicado: (2014)

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls
por: McMahon, James H., et al.
Publicado: (2021)

Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART
por: Cochrane, Catherine R., et al.
Publicado: (2022)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA
por: Tumpach, Carolin, et al.
Publicado: (2023)

Conformational alterations in the CD4 binding cavity of HIV-1 gp120 influencing gp120-CD4 interactions and fusogenicity of HIV-1 envelopes derived from brain and other tissues
por: Gray, Lachlan, et al.
Publicado: (2011)

Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders
por: Byrnes, Sarah J., et al.
Publicado: (2022)

The role of oxidative stress in HIV-associated neurocognitive disorders
por: Buckley, Sarah, et al.
Publicado: (2021)

A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection
por: Kroon, Eugène D.M.B., et al.
Publicado: (2020)

Intrahepatic CXCL10 is strongly associated with liver fibrosis in HIV-Hepatitis B co-infection
por: Singh, Kasha P., et al.
Publicado: (2020)

Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
por: Arandjelovic, Philip, et al.
Publicado: (2023)

Quantifying Susceptibility of CD4(+) Stem Memory T-Cells to Infection by Laboratory Adapted and Clinical HIV-1 Strains
por: Flynn, Jacqueline K., et al.
Publicado: (2014)

Ex Vivo Response to Histone Deacetylase (HDAC) Inhibitors of the HIV Long Terminal Repeat (LTR) Derived from HIV-Infected Patients on Antiretroviral Therapy
por: Lu, Hao K., et al.
Publicado: (2014)

HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
por: Roche, Michael, et al.
Publicado: (2011)

HIV cure research in the time of COVID-19 - Antiretroviral therapy treatment interruption trials: A discussion paper
por: Fidler, S., et al.
Publicado: (2020)

New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy
por: Wacleche, Vanessa Sue, et al.
Publicado: (2016)

Isolated Grade 5 Renal Trauma in a Hemodynamically Stable Patient
por: Dantanarayana, Nandu, et al.
Publicado: (2015)

Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
por: Sterjovski, Jasminka, et al.
Publicado: (2007)

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
por: Jaworowski, Anthony, et al.
Publicado: (2019)

Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
por: Fareh, Mohamed, et al.
Publicado: (2021)

Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
por: Cashin, Kieran, et al.
Publicado: (2013)

Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection
por: Jakobsen, Martin R., et al.
Publicado: (2013)

The Prion Protein N1 and N2 Cleavage Fragments Bind to Phosphatidylserine and Phosphatidic Acid; Relevance to Stress-Protection Responses
por: Haigh, Cathryn L., et al.
Publicado: (2015)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy
por: Chisenga, Caroline C., et al.
Publicado: (2015)

Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source
por: Gray, Lachlan, et al.
Publicado: (2007)

De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision
por: Hu, Wenxin, et al.
Publicado: (2022)

HIV latency reversing agents act through Tat post translational modifications
por: Khoury, Georges, et al.
Publicado: (2018)

Prion protein cleavage fragments regulate adult neural stem cell quiescence through redox modulation of mitochondrial fission and SOD2 expression
por: Collins, Steven J., et al.
Publicado: (2018)

CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies
por: Gray, L R, et al.
Publicado: (2016)

Impact of Vaccination on Distribution of T Cell Subsets in Antiretroviral-Treated HIV-Infected Children
por: Thitilertdecha, Premrutai, et al.
Publicado: (2017)

Normalization of B Cell Subsets but Not T Follicular Helper Phenotypes in Infants With Very Early Antiretroviral Treatment
por: Shalekoff, Sharon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f5evkc9deu4ui51mtp9iiiepqd